[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100593558":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":24,"locations":34,"responsibleParty":101,"collaborators":23,"id":103,"slug":104,"hasResults":105,"nctId":106,"briefTitle":107,"officialTitle":108,"acronym":109,"eligibilityCriteria":110,"healthyVolunteers":111,"sex":112,"minAge":113,"maxAge":114,"enrollmentInfo":115,"targetDuration":23,"studyType":118,"phases":119,"briefSummary":121,"conditions":122,"keywords":23,"overallStatus":37,"whyStopped":23,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":129,"completionDateStruct":131,"leadSponsor":133,"locationsCount":134},{"fullName":5,"class":6},"SightGlass Vision, Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"SightGlass Vision Test Arm Groups I (formerly test group)","EXPERIMENTAL","Single vision, impact-resistant spectacle lenses",[13],"Device: Novel spectacle lens design",{"label":15,"type":10,"description":11,"interventionNames":16},"SightGlass Vision Test Arm Groups II (formerly control group)",[13],[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"DEVICE","Novel spectacle lens design","Use of spectacle lenses may reduce the rate of progression of juvenile myopia",[9,15],null,[25,30],{"name":26,"role":27,"phone":28,"phoneExt":23,"email":29},"Jennifer S Hill, BS","CONTACT","678-361-4877","jhill@sightglassvision.com",{"name":31,"role":27,"phone":32,"phoneExt":23,"email":33},"Vanessa Tasso, MA, MBA","949-751-7039","vtasso@sightglassvision.com",[35,52,64,77,89],{"facility":36,"status":37,"city":38,"state":23,"zip":23,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Aier Eye Hospital","RECRUITING","Changsha","China","CN",{"type":42,"coordinates":43},"Point",[44,45],112.97087,28.19874,{"lat":45,"lon":44},[48,50],{"name":49,"role":27,"phone":23,"phoneExt":23,"email":23},"Xiaoning Li",{"name":49,"role":51,"phone":23,"phoneExt":23,"email":23},"PRINCIPAL_INVESTIGATOR",{"facility":53,"status":37,"city":54,"state":23,"zip":23,"country":39,"countryCode":40,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"West China Hospital","Chengdu",{"type":42,"coordinates":56},[57,58],104.06667,30.66667,{"lat":58,"lon":57},[61,63],{"name":62,"role":27,"phone":23,"phoneExt":23,"email":23},"Longqian Liu",{"name":62,"role":51,"phone":23,"phoneExt":23,"email":23},{"facility":65,"status":66,"city":67,"state":23,"zip":23,"country":39,"countryCode":40,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"Zhongshan Ophthalmic Center","NOT_YET_RECRUITING","Guangzhou",{"type":42,"coordinates":69},[70,71],113.25,23.11667,{"lat":71,"lon":70},[74,76],{"name":75,"role":27,"phone":23,"phoneExt":23,"email":23},"Xiao Yang",{"name":75,"role":51,"phone":23,"phoneExt":23,"email":23},{"facility":78,"status":37,"city":79,"state":23,"zip":23,"country":39,"countryCode":40,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"Fudan University EENT","Shanghai",{"type":42,"coordinates":81},[82,83],121.45806,31.22222,{"lat":83,"lon":82},[86,88],{"name":87,"role":27,"phone":23,"phoneExt":23,"email":23},"Peter Chen",{"name":87,"role":51,"phone":23,"phoneExt":23,"email":23},{"facility":90,"status":37,"city":91,"state":23,"zip":23,"country":39,"countryCode":40,"cosmosGeoPoint":92,"geoPoint":96,"contacts":97},"Tianjin Eye Hospital","Tianjin",{"type":42,"coordinates":93},[94,95],117.17667,39.14222,{"lat":95,"lon":94},[98,100],{"name":99,"role":27,"phone":23,"phoneExt":23,"email":23},"Lihua Li",{"name":99,"role":51,"phone":23,"phoneExt":23,"email":23},{"type":102,"investigatorFullName":23,"investigatorTitle":23,"investigatorAffiliation":23,"oldNameTitle":23,"oldOrganization":23},"SPONSOR","100593558","assessment-of-dot-spectacles-in-chinese-children-extension-100593558",false,"NCT07008001","Assessment of DOT Spectacles in Chinese Children Extension","Clinical Assessment of DOT Spectacle Lenses in Chinese Children Extension","CATHAY Ext","Inclusion Criteria:\n\n1. Previously a successfully completed participant in the CATHAY study (NCT05562622)\n2. Agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or otherwise not possible (minimum of 10 hours per day)\n3. Willingness to participate in the trial for 12 months without contact lens wear or any other myopia management intervention\n4. The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed copy of the form\n\nExclusion Criteria:\n\n1\\. Known allergy to proparacaine, tetracaine, or tropicamide or cyclopentolate",true,"ALL","8 Years","16 Years",{"count":116,"type":117},175,"ESTIMATED","INTERVENTIONAL",[120],"NA","This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.",[123,124],"Juvenile Myopia","Myopia","2025-12-24",{"date":127,"type":128},"2025-12-29","ACTUAL",{"date":130,"type":128},"2025-08-01",{"date":132,"type":117},"2026-12-31",{"name":5,"class":6},5]